✦ LIBER ✦

Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences

✍ Scribed by Henk J Broxterman; Jan Lankelma; Klaas Hoekman

Book ID: 117764510
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 286 KB
Volume: 6
Category: Article
ISSN: 1368-7646
DOI: 10.1016/s1368-7646(03)00026-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance against novel anticancer meta

Resistance against novel anticancer metal compounds: Differences and similarities

✍ Petra Heffeter; Ute Jungwirth; Michael Jakupec; Christian Hartinger; Markus Gala 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 708 KB

MRP Subfamily Transporters and Resistanc

MRP Subfamily Transporters and Resistance to Anticancer Agents

✍ Gary D. Kruh; Hao Zeng; Philip A. Rea; Guosheng Liu; Zhe-Sheng Chen; Kun Lee; Ma 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 69 KB

Platelet response to six agglutinating a

Platelet response to six agglutinating agents: Species similarities and differences

✍ R.G Mason; M.S Read 📂 Article 📅 1967 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Mechanisms of Resistance to Anti-Angioge

Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug Candidates

✍ Loges, S.; Schmidt, T.; Carmeliet, P. 📂 Article 📅 2010 🏛 Impact Journals, LLC 🌐 English ⚖ 702 KB

Potentiation of cytotoxic cancer therapi

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

✍ Beverly A. Teicher; Sylvia A. Holden; Gulshan Ara; Enrique Alvarez Sotomayor; Zh 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 724 KB

Emergence of potential biomarkers of res

Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents

✍ Agnieszka Michael; Kate Relph; Hardev Pandha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 190 KB

## Abstract Anti‐angiogenic agents targeting tumour vasculature have an established place in clinical practice, and new data are constantly emerging. However, despite rapid clinical uptake, a very large number of questions regarding these agents remain unanswered. One of the main hurdles in clinica